Alto Ingredients, Inc. ALTO

Latest FY: 2025 Basic Materials Specialty Chemicals
Market Price $4.16
Market Cap $325.44M
P/E Ratio 26.00
Quick Peer Compare (Basic Materials):
Revenue (FY 2025) ↓-4.9% YoY
$917.93M
3-Yr CAGR: 109.4%
Net Income ↑122.6% YoY
$13.34M
Net Margin: 1.5%
Free Cash Flow ↑159.3% YoY
$8.65M
FCF Yield: 2.66%
EPS (Diluted) ↑119.5% YoY
$0.16
Basic: $0.16
Return on Equity Efficiency
5.4%
ROA: 8.6%

📊 Multi-Year Historical Performance & Trends

Financial Performance History Revenue, Net Income & Free Cash Flow
Margins Trend (%) Gross, Operating & Net Margins
Balance Sheet Strength Cash, Debt & Equity
Cash Flow Generation Operating Cash Flow vs CapEx vs FCF

📈 Year-over-Year (YoY) Growth History (ALTO)

All monetary values in millions ($M)
Fiscal Year Revenue Revenue YoY Gross Profit Net Income Net Inc YoY Diluted EPS EPS YoY Op. Cash Flow Free Cash Flow FCF YoY
FY 2016 $1,624.8M $51.8M $1.4M $40.4M $21.2M
FY 2017 $1,632.3M +0.5% $5.9M $-35.0M -2,564.0% $-0.85 $36.5M $15.6M -26.3%
FY 2018 $1,515.4M -7.2% $-15.2M $-60.3M -72.4% $-1.42 -67.1% $1.6M $-13.6M -186.9%
FY 2019 $1,424.9M -6.0% $-9.9M $-88.9M -47.6% $-1.90 -33.8% $-23.4M $-26.6M -96.1%
FY 2020 $897.0M -37.0% $52.9M $-15.1M +83.0% $-0.28 +85.3% $71.8M $65.2M +344.7%
FY 2021 $1,207.9M +34.7% $67.8M $46.1M +404.9% $0.61 +317.9% $26.8M $10.4M -84.0%
FY 2022 $100.0M -91.7% $-27.6M $-41.6M -190.3% $-0.60 -198.4% $6.0M $-31.7M -403.7%
FY 2023 $1,222.9M +1,122.9% $15.7M $-28.0M +32.7% $-0.40 +33.3% $22.0M $-7.5M +76.3%
FY 2024 $965.3M -21.1% $9.7M $-59.0M -110.6% $-0.82 -105.0% $-3.5M $-14.6M -94.3%
FY 2025 $917.9M -4.9% $34.9M $13.3M +122.6% $0.16 +119.5% $13.2M $8.6M +159.3%
$

Valuation

Market Price $4.16
Market Cap $325.44M
Enterprise Value $381.65M
P/E Ratio 26.00
P/B Ratio 1.31
FCF Yield 2.66%
Dividend Yield N/A
Shares Outstanding 77,486,000
%

Profitability & Margins

Gross Margin 3.80%
Operating Margin 0.80%
Net Margin 1.45%
Return on Equity (ROE) 5.44%
Return on Assets (ROA) 8.55%
Asset Turnover 5.89x
Revenue 3-Yr CAGR 109.38%
🛡️

Financial Health & Liquidity

Current Ratio 9.34
Cash Ratio 1.40
Debt / Equity 0.325
Debt / Assets 0.511
Cash & Equivalents $23.41M
Total Debt $79.63M
Book Value / Share $3.16
💧

Cash Flow Efficiency

Operating Cash Flow $13.24M
Capital Expenditures (CapEx) $4.60M
Free Cash Flow $8.65M
OCF / Revenue 1.44%
FCF / Revenue 0.94%
FCF 3-Yr CAGR N/A
🏷️

Per Share Metrics

EPS (Diluted) $0.16
EPS (Basic) $0.16
Dividends / Share N/A
Book Value / Share $3.16
EPS YoY Growth 119.51%
🏛️

Balance Sheet (FY 2025)

Total Assets $155.92M
Total Liabilities $16.69M
Stockholders' Equity $245.24M
Current Assets $155.92M
Current Liabilities $16.69M